Like Healthimation, LLC

announced 7/27/2020 via BusinessWire

Nemaura Medical, Inc., will acquire Healthimation, LLC

synopsis: Nemaura Medical, Inc., a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT, is to acquire Healthimation, LLC, a company that offers an application-based diabetes prevention program.
buyer: Nemaura Medical, Inc. (NMRD:$0.00)
Nemaura Medical is a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. "
target: Healthimation, LLC
Healthimation is commercializing an application-based diabetes prevention program that has been developed over a period of over 12 years and is supported with clinical data that has been widely published in scientific journal articles.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2020 via BusinessWire

Tandem Diabetes Care, Inc., acquired Sugarmate, Inc.

synopsis: Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, has acquired Sugarmate, a popular mobile app for people with diabetes who use insulin. The Sugarmate app is designed to help people with diabetes visualize diabetes therapy data in innovative ways.
buyer: Tandem Diabetes Care, Inc. (TNDM:$394.24)
Tandem Diabetes Care is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. "
target: Sugarmate, Inc.
Sugarmate is a mobile application designed to help people with diabetes visualize diabetes therapy data in innovative ways. It allows users to log glucose data and health and nutrition information, and can provide notifications and alerts to users, their family, and their caregivers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/16/2020 via BNC Analysis

Huma, acquired BioBeats

synopsis: UK-based Huma has acquired BioBeats, a digital health company. Headquartered in London, BioBeats uses AI and Machine Learning in conjunction with biometrics to provide personalized stress and productivity tools. BioBeats' app BioBase pairs with biosensors and wearable devices to gather biometric data, such as heart rate variability.
buyer: Huma
UK-based Huma partners with scientists, technologists, and healthcare professionals to understand, treat, and ultimately prevent ill health. Huma gives knowledge and power to those with medical conditions while saving clinicians time, energy, and valuable resources. "
target: BioBeats
UK-based BioBeats is a digital health company and developer of BioBase, a mental health and wellbeing support app. BioBase pairs with biosensors and wearable devices to gather biometric data that is used in conjunction with AI and machine learning to develop personalized stress management tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BNC Analysis

Tmm Software, acquired Mental Apps SAS

synopsis: Tmm Software, a French group that develops e-health software solutions for healthcare institutions, healthcare professionals, and patients, has acquired the Lyon-based Mental Apps, a digital health company dedicated to mental disorders. Mental Apps helps psychiatrists and general practitioners follow their patients between consultations.
buyer: Tmm Software
France-based Tmm Software develops e-health software solutions for healthcare institutions, healthcare professionals and patients. TMM Software markets three software solutions, MultiMed, apTeleCare, and apFamilyLink, available to healthcare professionals and patients. "
target: Mental Apps SAS
Created in 2016 by Dr. Laurent Zukervar, Mental Apps is a French digital health company dedicated to mental disorders. Its mobile solutions help psychiatrists and general practitioners better follow their patients between consultations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/23/2022 via Company Press Release

WellSky, will acquire Tapcloud LLC

synopsis: WellSky, a global health and community care technology company, will acquire TapCloud, a virtual patient engagement technology company that helps patients, caregivers, and clinicians to communicate crucial information in real-time. Their AI-driven platform provides patient-generated insights that enable providers to deploy care interventions.
buyer parent: TPG Capital
buyer: WellSky
WellSky is a technology company advancing human wellness. Its software and professional services address the continuum of health and social care by helping businesses, organizations, and communities solve challenges, improve collaboration, and achieve better outcomes through predictive insights. "
target: Tapcloud LLC
TapCloud is a virtual patient engagement technology company. TapCloud helps patients, caregivers, and clinicians to communicate crucial information in real-time. Their AI-driven platform provides patient-generated insights that enable providers to deploy care interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2022 via BNC Analysis

Docprime Technologies, acquired Visit

synopsis: Docprime Technologies, India’s 1st digital health locker, has acquired a 98.4% stake in Visit Internet Services Pvt Ltd, an AI-powered telemedicine platform in India. Visit provides a mobile platform that allows patients to connect with top healthcare specialists over video/voice call within 30 minutes.
buyer parent: PB Fintech Limited
buyer: Docprime Technologies
Docprime is India’s 1st digital health locker. Docprime aims to redefine how Indians seek healthcare services. Their mobile and online platform allows patients to securely store and manage all of their personal health records online. Their solution makes it easier to share records with doctors. "
target: Visit
Visit is an AI-powered telemedicine platform in India. Visit provides a mobile platform that allows patients to connect with top healthcare specialists over video/voice call within 30 minutes. The app also enables users to easily check their symptoms, track fitness activity, and log their meals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/18/2022 via BNC Analysis

iZafe, will acquire Pilloxa

synopsis: iZafe Group AB (publ), a Swedish Life-Science company, will acquire Pilloxa AB, a Swedish company that aims to make people healthier through technology. Pilloxa develops branded apps for patients to support them in adherence to their treatment and to connect patients, healthcare providers and the pharmaceutical industry.
buyer: iZafe (OM:IZAFE B:$0.04)
iZafe is a Swedish Life-Science company. iZafe develops medical and digital security solutions to create safer drug handling at home. The company's digital medication dispenser, Dosell, reduces the risk of incorrect medication, increases security for family, and relieves public care personnel. "
target: Pilloxa
Pilloxa is a Swedish company that aims to make people healthier through technology. Pilloxa develops branded apps for patients to support them in adherence to their treatment and to connect patients, healthcare providers and the pharmaceutical industry.
price ($mm)
$2.94
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2021 via GlobeNewswire

CareDx, Inc, acquired Transplant Hero LLC

synopsis: CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, has acquired Transplant Hero LLC, a New York-based provider of a mobile application supporting the needs of transplant patients.
buyer: CareDx, Inc (CDNA:$275.82)
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions along the pre- and post-transplant patient journey. "
target: Transplant Hero LLC
Transplant Hero is the developer of a mobile application that supports the needs of transplant patients. Transplant Hero is an interactive, educational, and simple to use tool that offers users positive reinforcement for medication adherence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2020 via BNC Analysis

Tmm Software, acquired Hospiteasy

synopsis: TMM Software, a French developer of e-health software solutions, has acquired Hospiteasy, a French mobile app that connects patients to their doctors and hospitals. Hospiteasy simplifies hospital admissions by enabling patients to fill out and send in their admission forms from their phones before they arrive.
buyer: Tmm Software
France-based Tmm Software develops e-health software solutions for healthcare institutions, healthcare professionals and patients. TMM Software markets three software solutions, MultiMed, apTeleCare, and apFamilyLink, available to healthcare professionals and patients. "
target: Hospiteasy
Hospiteasy is a French mobile app that connects patients to their doctors and hospitals. Hospiteasy simplifies hospital admissions by enabling patients to fill out and send in their admission forms from their phones before they arrive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2020 via PR Newswire

The DNA Company, acquired My Pain Sensei

synopsis: Canada-based The DNA Company has acquired AI-based digital therapeutics app My Pain Sensei (MPS), forming My Next Health. The DNA Company specializes in understanding how genes and genetic pathways influence health and wellness, and the acquisition of MPS gives My Next Health an AI-based platform to develop multiple health applications.
buyer: The DNA Company
The DNA Company is a Canadian functional genomics company that provides evidence-based therapies based on genomic insights that identify how genes and genetic pathways influence health and wellness. "
target: My Pain Sensei
My Pain Sensei (MPS) is an AI-based digital therapeutics app that helps users understand, manage, and communicate their chronic pain. MPS helps identify users' potential conditions with its Quick Assessment feature and creates a detailed and multi-dimensional Pain Report for care providers.
price ($mm)
$30
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/10/2022 via BNC Analysis

Infohealth Ltd, acquired Quin

synopsis: Infohealth Ltd, a leading UK pharmacy-led developer of hyper-personalised digital health solutions, has acquired Quin Technology, a diabetes management app in the UK. Quin helps people to manage their Type 1 diabetes. The AI-powered app allows users to record and plan their food, insulin and activity, and provides them with personalized insights.
buyer: Infohealth Ltd
Infohealth is a leading UK pharmacy-led developer of hyper-personalised digital health solutions. Infohealth's business operations include pharmacies, a telehealth mobile app, pharmaceutical manufacturing, and medicines management services for care homes. "
target: Quin
Quin is a diabetes management app in the UK. Quin helps people to manage their Type 1 diabetes. The app allows users to record and plan food, insulin and activity to see how each affects their blood sugar. Their app uses AI to provide personalized insights based on the user's data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/23/2022 via BusinessWire

Afya Participações S.A., acquired Glic

synopsis: Afya Limited announced the acquisition, through its wholly-owned subsidiary Afya Participações S.A, of 100% of Glic. Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and health providers.
buyer parent: Afya Limited
buyer: Afya Participações S.A.
Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners. "
target: Glic
Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and health providers.
price ($mm)
$4.52
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/16/2022 via BNC Analysis

Glooko, acquired Diabnext

synopsis: Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, has acquired Diabnext, a diabetes management app in France. Diabnext enables people with diabetes to better manage their health by automatically collecting data into a digital logbook.
buyer: Glooko
Glooko is a provider of remote patient monitoring and digital health solutions. Glooko is transforming digital health by connecting people with diabetes and other chronic conditions with their healthcare teams, enabling collaborative telehealth, clinical research and improved health outcomes. "
target: Diabnext
Diabnext is a diabetes management app in France. Diabnext helps people with diabetes to better manage their health and stay connected with their healthcare providers. The app enables users to better manage their diabetes by automatically collecting data into a digital logbook.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/11/2017 via BNC Analysis

StayWell, acquired MedHelp

synopsis: StayWell, a health engagement company, has acquired MedHelp, the largest online health community and consumer health platform. MedHelp empowers 19 million users a month to better understand and better manage their health. They also provide mobile apps such as My Diet Diary, a calorie tracking app, and Sugar Sense, a top-ranked diabetes app.
buyer parent: Merck & Co., Inc.
buyer: StayWell
StayWell is a health engagement company that helps its clients engage and educate people to improve health and business results. StayWell brings decades of experience working across the health care industry to design solutions that address its clients’ evolving needs. "
target: MedHelp
MedHelp is the largest online health community and consumer health platform, empowering 19 million unique users a month to better understand and better manage their health. MedHelp also provides mobile apps such as My Diet Diary, a calorie tracking app, and Sugar Sense, a top-ranked diabetes app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/30/2017 via Company Press Release

Roche Ltd, acquired mySugr GmbH

synopsis: Roche and mySugr announced that the two partners have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: mySugr GmbH
mySugr specializes in all-around care for people with diabetes. Its apps and services combine diabetes coaching, therapy management, unlimited test-strips, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2014 via PR Newswire

Physicians Interactive, acquired MedHelp

synopsis: Physicians Interactive, a leading provider of online and mobile clinical resources and solutions for healthcare professionals, announced the acquisition of MedHelp, the online health community and health application site.
buyer parent: Merck & Co., Inc.
buyer: Physicians Interactive
Physicians Interactive is a provider of online and mobile clinical resources and solutions for healthcare professionals. PI uses the power of networks of healthcare professionals and life sciences companies together in ways that will change the practice and business of medicine for the better. "
target: MedHelp
MedHelp is the world's largest online health community and consumer health platform, empowering 14 million unique users a month to better understand and better manage their health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via GlobeNewswire

BioTelemetry, acquired Telcare

synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer: BioTelemetry (BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
target: Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2016 via BusinessWire

merged with Glooko,

synopsis: In a move that will accelerate the mission to make diabetes management easier worldwide, Glooko and Diasend announced they have merged into a unified company. Glooko and Diasend are well-known for making diabetes management easier by offering diabetes management and analytics platforms that facilitate data driven care for patients and clinicians.
buyer: Glooko
Glooko is the leading remote patient monitoring platform for diabetes and is trusted by the world’s leaders in diabetes care. Glooko's mobile app enables patients to easily track and proactively manage all aspects of their diabetes care. "
target:
Diasend simplifies life for people with diabetes and facilitates the work of their health care providers by optimizing diabetes data management. The company transmits, stores, and analyzes data from more than 140 glucose meters, insulin pumps, CGM systems and leading activity trackers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2022 via GlobeNewswire

ResMed, acquired mementor DE GmbH

synopsis: ResMed announced the acquisition of Leipzig-based company mementor. mementor developed and owns the digital insomnia therapy solution somnio, which is Germany’s first and only permanently approved Digital Health Application (DiGA) in the field of sleep medicine and thus eligible for reimbursement in Germany.
buyer: ResMed (RMD:$3,443.76)
ResMed, a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. "
target: mementor DE GmbH
Founded in 2014 and based in Leipzig, Germany, mementor developed and owns the digital insomnia therapy solution somnio, which is Germany’s first and only permanently approved Digital Health Application (DiGA) in the field of sleep medicine and thus eligible for reimbursement in Germany.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/16/2022 via BusinessWire

Medable, acquired Omhu A/S

synopsis: Medable Inc., the leading software provider for patient-centered clinical trials, announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
buyer: Medable
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials. "
target parent: LEO Pharma Inc.
target: Omhu A/S
Omhu is a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. Omhu’s software applications include Imagine, a skin-tracking mobile app, and Omhu Care, a telemedicine app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/27/2020 via BusinessWire

Nemaura Medical, Inc., will acquire Healthimation, LLC

synopsis: Nemaura Medical, Inc., a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT, is to acquire Healthimation, LLC, a company that offers an application-based diabetes prevention program.
buyer: Nemaura Medical, Inc. (NMRD:$0.00)
Nemaura Medical is a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. "
target: Healthimation, LLC
Healthimation is commercializing an application-based diabetes prevention program that has been developed over a period of over 12 years and is supported with clinical data that has been widely published in scientific journal articles.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/27/2020 via BusinessWire

Nemaura Medical, Inc., will acquire Healthimation, LLC

synopsis: Nemaura Medical, Inc., a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT, is to acquire Healthimation, LLC, a company that offers an application-based diabetes prevention program.
buyer: Nemaura Medical, Inc. (NMRD:$0.00)
Nemaura Medical is a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. "
target: Healthimation, LLC
Healthimation is commercializing an application-based diabetes prevention program that has been developed over a period of over 12 years and is supported with clinical data that has been widely published in scientific journal articles.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/5/2020 via GlobeNewswire

Livongo will be merged with TelaDoc, Inc.,

synopsis: Teladoc Health, the global leader in virtual care, and Livongo, the leading Applied Health Signals company, have entered into a definitive merger agreement. The combination of Teladoc Health and Livongo will create a global leader in consumer centered virtual care. The combined company will operate under the Teladoc Health brand.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is recognized as the world leader in virtual care. They deliver millions of medical visits across 175 countries annually through the Teladoc Health Medical Group, enabling millions of patient and provider touchpoints for hospitals, health systems, and physician practices globally. "
target: Livongo (LVGO:$257.96)
Livongo empowers people with chronic conditions to live better and healthier lives. Using its AI+AI engine, Livongo aggregates and interprets health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them.
price ($mm)[EV]
$16,988 [$16,567]
rev ($mm)
$258
EBITDA ($mm)
EV / rev
70.8x
EV / EBITDA
announced 6/3/2020 via BusinessWire

BreathResearch will be merged with AireHealth,

synopsis: AireHealth Inc., a company that offers affordable treatments, symptom tracking and early detection of respiratory conditions, has reached a merger agreement with BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status.
buyer: AireHealth
AireHealth offers affordable treatments, symptom tracking and early detection of respiratory conditions. The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. "
target: BreathResearch
BreathResearch is an innovative healthcare company that offers a solution that converts the air waves from breathing into sound waves producing new respiratory analytics to improve health, fitness and performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via GlobeNewswire

BioTelemetry, acquired Telcare

synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer: BioTelemetry (BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
target: Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/14/2018 via BNC Analysis

MindMaze, acquired Neuro Motor Innovations Corporation

synopsis: MindMaze, operator of a platform that captures brain activity announced its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI). NMI is a medical technology company with a mission to improve movement and cognition outcomes through their brain repair therapy.
buyer: MindMaze
MindMaze operates a platform that captures brain activity, creating a new operating system for computers - a brain O/S. They designed an intuitive mind/machine interface, which utilizes pre-realtime decoding of brain signals via neural prediction, transforming healthcare and gaming industries. "
target: Neuro Motor Innovations Corporation
Neuro Motor Innovations (NMI) is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients. NMI’s solution includes a proprietary medical gaming platform, game therapy software, and hardware control devices for hand, arm, foot and face.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/30/2022 via BusinessWire

Linus Health, acquired Kinesis Health Technologies

synopsis: Linus Health, a Boston-based digital health company focused on brain health, announced the completion of its acquisition of Kinesis Health Technologies, a Dublin-based leader in physical function assessment for older adults.
buyer: Linus Health
Linus Health is a digital health company focused on transforming brain health for people across the world. By advancing how we detect, diagnose, and address cognitive and brain disorders, their goal is to enable a future where people can live longer and healthier lives with better brain health. "
target: Kinesis Health Technologies
Kinesis Health Technologies Limited is an award-winning digital health company based in Dublin, Ireland. Kinesis solutions utilize sensors, artificial intelligence, and machine learning to produce comprehensive and accurate assessments of gait, mobility, balance, and falls risk in older adults.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/31/2015 via PR Newswire

Nuvon, Inc. will be merged with Bernoulli Enterprise, Inc.,

synopsis: Cardiopulmonary Corp., a leader in real-time connected healthcare and Nuvon, a leader in medical device integration, interoperability, and clinical intelligence, announced that they have entered into a definitive agreement for Nuvon to merge with Cardiopulmonary Corp.
buyer: Bernoulli Enterprise, Inc.
Cardiopulmonary Corp. is a leader in real-time connected healthcare. Its flagship Bernoulli Enterprise system provides a platform for Medical Device Connectivity, Alarm Management, Virtual ICU and Analytics to enable better outcomes, reduce the cost of care and improve patient/staff satisfaction. "
target: Nuvon, Inc.
Nuvon's mission is to transform medicine by delivering critical Patient Care Data at the point of care. Nuvon's FDA cleared Class I and Class II Medical Device Connectivity and Clinical Intelligence Systems connect and automates the capture of Patient Care Data from medical devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2017 via BNC Analysis

B.Braun Medical Inc., acquired BPMpathway

synopsis: B. Braun, one of the world’s leading manufacturers of medical devices and pharmaceutical products, has acquired 270 Vision Limited (BPMpathway), a UK-based developer of wearable sensor technology. BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
buyer: B.Braun Medical Inc.
B. Braun is a German medical and pharmaceutical device company, which has offices and facilities in more than 50 countries. Its headquarters are located in the small town of Melsungen, in central Germany. "
target: BPMpathway
BPMpathway (270 Vision Limited) is a UK-based developer of wearable sensor technology. Product design and development company BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2013 via Market Watch

Medtronic, Inc., acquired CardioCom

synopsis: Medtronic, Inc., the global leader in medical technology, announced the closing of the acquisition of Cardiocom, a privately held developer and provider of integrated telehealth and patient services for the management of chronic diseases, in an all cash transaction valued at $200 million.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. "
target: CardioCom
Cardiocom is a proven leader in Integrated Clinical Telehealth Services. Cardiocom is a world-class developer, manufacturer and clinical telehealth solutions provider with cutting-edge, yet user-friendly telemonitoring products and services.
price ($mm)
$200
rev ($mm)
$50
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 2/13/2020 via Company Press Release

Medtronic, Inc., acquired Digital Surgery

synopsis: Medtronic, the global leader in medical technology, announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic is among the world’s largest medical technology, services and solutions companies, alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients. "
target: Digital Surgery
Headquartered in London, England, Digital Surgery’s mission is to digitize surgical protocols using cutting-edge computing and to support the delivery of consistent, data-driven and evidence-based surgical care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/18/2020 via Company Press Release

AccuReg Software, acquired Zenig

synopsis: AccuReg, a healthcare technology solutions company offering a full suite of front-end revenue cycle management solutions, has acquired Orlando-based Zenig, an innovator in patient engagement technology solutions that enable touchless check-in, virtual waiting rooms, patient flow and bi-directional communication methods.
buyer: AccuReg Software
AccuReg helps hospitals reduce costs, maximize revenue and enable price transparency and digital patient engagement with its market-leading digital patient access solutions. Its cloud-based integrated suite utilizes automation and intelligence to improve patient experience. "
target: Zenig
Zenig offers patient engagement technology solutions. Zenig humanizes the patient experience by engaging with patients throughout their healthcare journeys. The automated journey begins with appointment reminders.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2018 via BusinessWire

TransEnterix, Inc., acquired MST Medical Surgery Technologies Ltd.

synopsis: TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, has acquired MST Medical Surgery Technologies Ltd. (MST), an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment.
buyer: TransEnterix, Inc. (AMEX:TRXC:$14.74)
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery. Their Senhance Surgical Robotic System is a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. "
target: MST Medical Surgery Technologies Ltd.
MST Medical Surgery Technologies Ltd. (MST) is an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery (MRCAS).
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/18/2022 via GlobeNewswire

ASSA ABLOY AB, will acquire Vigil Health Solutions

synopsis: Vigil Health Solutions, a leader in innovative call systems and resident monitoring solutions for senior living, is to be acquired by ASSA ABLOY, the global leader in door opening solutions, dedicated to satisfying end user needs for security, safety and convenience.
buyer: ASSA ABLOY AB (OM:ASSA B:$10,395.79)
Based in Sweden, ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end user needs for security, safety and convenience. The Group has a leading position in areas such as access control, identification technology, entrance automation and hotel security. "
target: Vigil Health Solutions (VGL:$5.16)
Vigil Health Solutions is a leader in innovative call systems and resident monitoring solutions for senior living. The Vigil Integrated Care Management System is the one platform that addresses resident needs throughout the full continuum of care.
price ($mm)[EV]
$12 [$9]
rev ($mm)
$5
EBITDA ($mm)
$1
EV / rev
1.9x
EV / EBITDA
10.6x
closed 4/17/2019 via Company Press Release

Sentrics, acquired Silversphere

synopsis: Sentrics, the emerging industry leader that provides integrated technologies to the senior living industry, announced it has acquired Silversphere. Silversphere delivers a suite of interconnected solutions to senior living communities that detect, alert and predict resident needs that help caregivers deliver proactive care and prevent emergencies.
buyer parent: Periscope Equity
buyer: Sentrics
Sentrics is an integrated system of data-driven technology companies enabling greater transparency into the quality of life for residents, providers and families. Sentrics partners with senior living operators to strengthen focus on the total well-being of each resident. "
target: Silversphere
Silversphere is a senior living specific technology company that, for over 70 years, has been dedicated to improving the lives of seniors and their caregivers. Silversphere designs, manufactures, installs, and supports emergency call systems, nurse call systems, resident monitoring, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2014 via PR Newswire

Henry Schein, Inc., acquired Julie Owandy Group

synopsis: Henry Schein, Inc., the world's largest provider of healthcare products and services, announced the signing of an agreement to acquire five businesses operating in three European countries from Arseus NV. One of the businesses is the leading dental practice management software company in France, Logiciel Julie.
buyer: Henry Schein, Inc. (HSIC:$13,288.81)
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. "
target parent: Arseus NV
target: Julie Owandy Group
Owandy is an international player and is renowned for manufacturing dental imaging solutions and developing imaging and practice management software. Its software is used by around half of the dental practitioners in France.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 8/15/2012 via BNC Analysis

Alere, acquired MedApps, Inc.

synopsis: Waltham, Massachusetts-based Alere acquired wireless remote patient monitoring company MedApps. MedApps is dedicated to developing innovative remote health monitoring solutions that deliver efficient cost-effective connectivity between patient, care provider and electronic medical records.
buyer: Alere (ALR:$2,818.83)
Alere provides disease management services by connecting a unique blend of at-home monitoring technology, patient-empowering education, and nurse-patient relations to improve the daily lives people with heart failure. "
target: MedApps, Inc.
MedApps, Inc. develops mobile health monitoring systems. The company’s solutions link patients, families, and healthcare providers using cellular technology to collect, store, and report health information.
price ($mm)
$22
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/5/2012 via PR Newswire

Varian Medical Systems, Inc., will acquire InfiMed, Inc.

synopsis: Varian Medical Systems, Inc., announced it has reached an agreement to acquire InfiMed, Inc., a privately-owned, leading supplier of workstations including hardware and software for processing diagnostic X-ray images.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. "
target: InfiMed, Inc.
Since 1983, InfiMed, Inc. has been a developer of digital medical acquisition, image processing, and sensor solutions. These systems are used in hospital Cath Labs, X-ray departments, imaging centers, and trauma centers worldwide.
price ($mm)
$15
rev ($mm)
$15
EBITDA ($mm)
EV / rev
1.0x
EV / EBITDA
announced 5/4/2009 via Company Description

Philips Electronics NV, will acquire Traxtal Inc.

synopsis: Royal Philips Electronics announced that it has acquired Canada-based Traxtal Inc., an innovative medical technology company in the field of minimally-invasive instruments and software for image-guided intervention and therapy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$22,796.71)
Royal Philips Electronics is a global leader in healthcare, lighting and consumer lifestyle, delivering products, services and solutions. The company has medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, home appliances, as well as consumer electronics. "
target: Traxtal Inc.
Traxtal, Inc. engages in the development and manufacture of computer assisted soft tissue navigation technologies. It offers PercuNav system, an image-guided diagnostic and interventional system for various imaging modalities.
price ($mm)
$24
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/11/2008 via BNC Analysis

Arseus NV, acquired Julie Owandy Group

synopsis: Advised by Close Brothers, Arseus NV, listed on the Eurolist in Brussels and Amsterdam, has acquired the Julie-Owandy group. Founded in 1997, the Julie-Owandy group is the French leading provider of software for dentists (over 14,000 dentists equipped out of 35,000 in France) and one of the leaders of dental imaging equipment.
buyer: Arseus NV (FAGR:$473.30)
Arseus is a multinational group of companies that provides products, services and concepts for professionals and institutions active in the healthcare sector in Europe. "
target: Julie Owandy Group
Owandy S.A. focuses on specific software and sales of IT equipment. We have introduced the first digital auto-focus camera and cable free sensor UPIX. Our X-ray unit comprises of elios ac and altis dc. The altis dc generator guarantees consistent exposure settings.
price ($mm)[EV]
$34 [$37]
rev ($mm)
$37
EBITDA ($mm)
EV / rev
0.8x
EV / EBITDA
announced 6/6/2018 via BNC Analysis

Philips Electronics NV, will acquire EPD Solutions Ltd.

synopsis: Royal Philips, a global leader in health technology, will acquire EPD Solutions from the Hobart Group, an international portfolio of medical device companies. EPD specializes in making cardiac imaging and navigation systems that help electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$22,796.71)
Based in the Netherlands, Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
target parent: Hobart Group (Medical Device)
target: EPD Solutions Ltd.
EPD Solutions (EPD) is dedicated to improving the efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias. EPD's cardiac imaging and navigation system helps electrophysiologists navigate the heart by generating a detailed 3D image of the cardiac anatomy.
price ($mm)
$292
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Healthimation, LLC


read more

Healthimation, LLC

Sugarmate, Inc.

BioBeats

Mental Apps SAS

Tapcloud LLC

Visit

Pilloxa

Transplant Hero LLC

Hospiteasy

My Pain Sensei

Quin

Glic

Diabnext

MedHelp

mySugr GmbH

MedHelp

Telcare

mementor DE GmbH

Omhu A/S

read more

Healthimation, LLC

read more

Healthimation, LLC

read more

Livongo

BreathResearch

Telcare

Neuro Motor Innovations Corporation

Kinesis Health Technologies

ImPACT Concussion Management

Nuvon, Inc.

BPMpathway

CardioCom

Digital Surgery

Zenig

MST Medical Surgery Technologies Ltd.

Vigil Health Solutions

Silversphere

Julie Owandy Group

MedApps, Inc.

InfiMed, Inc.

Traxtal Inc.

Julie Owandy Group

EPD Solutions Ltd.

Geography
Matching Companies
Ticker: HLSE:HEALTH
 
 
 
 
 
 
 
 
Nightingale Health Plc
Nightingale Health Plc
Nightingale Health is a Finnish health technology company. Nightingale's mission is to bring disease prevention and a healthier life within everyone's reach. They offer a mobile blood testing platform that allows users to easily understand their current health and improve their wellbeing.
year
2020
rev ($mm)
$2.65
EBITDA ($mm)
($4.36)
EBIT ($mm)
($4.51)
Net Income ($mm)
Employees
77
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: CNSX:NARA
 
 
 
 
 
 
 
 
PanGenomic Health Inc.
PanGenomic Health Inc.
PanGenomic is a digital health platform in Canada. PanGenomic provides people with personal control over their mental health treatments. Their Nara solution is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness.
year
2021
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.26)
Net Income ($mm)
Employees
5
  • drill down
  • watch
Ticker: OM:COALA
 
 
 
 
 
 
 
 
Coala Life
Coala Life
Coala Life is a Swedish medical device company focused on cloud-based cardiac and pulmonary diagnostics. Coala Life's Coala Heart Monitor is a cloud-based product and app that enables long-term remote monitoring, analysis and algorithm-based diagnostics of the heart.
year
2021
rev ($mm)
$0.41
EBITDA ($mm)
($5.86)
EBIT ($mm)
($5.95)
Net Income ($mm)
Employees
29
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2021
rev ($mm)
$26.91
EBITDA ($mm)
($10.89)
EBIT ($mm)
($11.69)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:ADHC
 
 
 
 
 
 
 
 
American Diversified Holdings Corporation
American Diversified Holdings Corporation
American Diversified Holdings Corporation (ADHC) is a publicly traded holding company providing executive management, corporate governance, administrative support, financial advisory services, investment capital sourcing, and regulatory affairs to both private and public companies.
year
2012
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.45)
Net Income ($mm)
Employees
3
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
39
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: NMRD
 
 
 
 
 
 
 
 
Nemaura Medical, Inc.
Nemaura Medical, Inc.
Nemaura Medical is a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT.
year
2020
rev ($mm)
EBITDA ($mm)
($4.72)
EBIT ($mm)
($4.78)
Net Income ($mm)
Employees
17
  • drill down
  • watch
Ticker: RMD
 
 
 
 
 
 
 
 
ResMed
ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases.
year
2022
rev ($mm)
$3,443.76
EBITDA ($mm)
$1,161.78
EBIT ($mm)
$970.99
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: SPA
 
 
 
 
 
 
 
 
Sparton Corporation
Sparton Corporation
Sparton Corporation, now in its 115th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service, and refurbishment.
year
2014
rev ($mm)
$338.86
EBITDA ($mm)
$32.07
EBIT ($mm)
$23.21
Net Income ($mm)
$10.89
Employees
1385
  • drill down
  • watch
Ticker: OM:IZAFE B
 
 
 
 
 
 
 
 
iZafe
iZafe
iZafe is a Swedish Life-Science company. iZafe develops medical and digital security solutions to create safer drug handling at home. The company's digital medication dispenser, Dosell, reduces the risk of incorrect medication, increases security for family, and relieves public care personnel.
year
2021
rev ($mm)
$0.04
EBITDA ($mm)
($3.10)
EBIT ($mm)
($3.10)
Net Income ($mm)
Employees
8
  • drill down
  • watch
Ticker: SGN
 
 
 
 
 
 
 
 
Signalife, Inc.
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring.
year
2007
rev ($mm)
EBITDA ($mm)
($14.36)
EBIT ($mm)
($14.46)
Net Income ($mm)
Employees
15
  • drill down
  • watch
Ticker: HAE
 
 
 
 
 
 
 
 
Haemonetics Corporation
Haemonetics Corporation
Haemonetics is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions. Their technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
year
2020
rev ($mm)
$988.48
EBITDA ($mm)
$266.02
EBIT ($mm)
$173.83
Net Income ($mm)
$76.53
Employees
3004
  • drill down
  • watch
Ticker: BABY
 
 
 
 
 
 
 
 
Natus Medical, Incorporated
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment and neurological dysfunction.
year
2014
rev ($mm)
$352.46
EBITDA ($mm)
$64.99
EBIT ($mm)
$54.44
Net Income ($mm)
$30.91
Employees
943
  • drill down
  • watch
Ticker: HOLX
 
 
 
 
 
 
 
 
Hologic, Inc.
Hologic, Inc.
Hologic is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of state-of-the-art digital imaging technology for general radiography and mammography applications.
year
2011
rev ($mm)
$1,789.35
EBITDA ($mm)
$595.38
EBIT ($mm)
$290.64
Net Income ($mm)
$157.15
Employees
5019
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: MASI
 
 
 
 
 
 
 
 
Masimo
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions.
year
2019
rev ($mm)
$913.46
EBITDA ($mm)
$234.73
EBIT ($mm)
$213.99
Net Income ($mm)
$190.23
Employees
1500
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: ASX:PGC
 
 
 
 
 
 
 
 
Paragon Care
Paragon Care
Paragon Care is a company focused on Hospital & Healthcare services and has progressively acquired businesses in the healthcare sector. It is a leading provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market.
year
2018
rev ($mm)
$98.79
EBITDA ($mm)
$9.27
EBIT ($mm)
$8.09
Net Income ($mm)
$7.91
Employees
508
  • drill down
  • watch
Ticker: ENXTPA:ALVMG
 
 
 
 
 
 
 
 
Visiomed Group SA
Visiomed Group SA
Founded in 2007, Visiomed Group is a company that specializes in next-generation medical electronics. The laboratory develops and markets innovative healthcare products in the promising areas of self-diagnosis for medical use and well-being.
year
2017
rev ($mm)
$11.54
EBITDA ($mm)
($16.87)
EBIT ($mm)
($17.34)
Net Income ($mm)
Employees
102
  • drill down
  • watch
Ticker: OM:COALA
 
 
 
 
 
 
 
 
Coala Life
Coala Life
Coala Life is a Swedish medical device company focused on cloud-based cardiac and pulmonary diagnostics. Coala Life's Coala Heart Monitor is a cloud-based product and app that enables long-term remote monitoring, analysis and algorithm-based diagnostics of the heart.
year
2021
rev ($mm)
$0.41
EBITDA ($mm)
($5.86)
EBIT ($mm)
($5.95)
Net Income ($mm)
Employees
29
  • drill down
  • watch
Ticker: ILMN
 
 
 
 
 
 
 
 
Illumina, Inc.
Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets.
year
2020
rev ($mm)
$3,556.00
EBITDA ($mm)
$1,198.00
EBIT ($mm)
$1,013.00
Net Income ($mm)
$942.00
Employees
7700
  • drill down
  • watch